Compare SPNT & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPNT | TWST |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 3.0B |
| IPO Year | N/A | 2018 |
| Metric | SPNT | TWST |
|---|---|---|
| Price | $20.67 | $47.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $24.00 | ★ $48.75 |
| AVG Volume (30 Days) | 537.2K | ★ 960.6K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | N/A | $18.89 |
| Revenue Next Year | $5.83 | $15.28 |
| P/E Ratio | $5.65 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $14.76 | $23.30 |
| 52 Week High | $22.89 | $57.88 |
| Indicator | SPNT | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 52.12 |
| Support Level | $19.02 | $25.67 |
| Resistance Level | $20.83 | $57.88 |
| Average True Range (ATR) | 0.54 | 2.61 |
| MACD | -0.08 | -0.55 |
| Stochastic Oscillator | 47.17 | 62.13 |
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.